168 related articles for article (PubMed ID: 26043680)
21. [The hemodynamic profile of pentaerythrityl tetranitrate].
Engelmann L; Gottschild D
Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
[TBL] [Abstract][Full Text] [Related]
22. Impact of functional testing results on prescription patterns of anti-anginal medication after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry.
; Wou K; Nguyen H; Duerr R; Del Core M; Fourchy D; Huynh T; Lader E; Rogers FJ; Chaudhry R; Pilote L; Eisenberg MJ
J Invasive Cardiol; 2006 Jun; 18(6):278-82. PubMed ID: 16751682
[TBL] [Abstract][Full Text] [Related]
23. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.
Grootendorst PV; Dolovich LR; O'Brien BJ; Holbrook AM; Levy AR
CMAJ; 2001 Oct; 165(8):1011-9. PubMed ID: 11699696
[TBL] [Abstract][Full Text] [Related]
24. Quantitative determination of pentaerythrityl tetranitrate and its metabolites in human plasma by gas chromatography/mass spectrometry.
Stalleicken D; Kuntze U; Schmid B; Hiebl R; Ring J; Michaelis K
Arzneimittelforschung; 1997 Apr; 47(4):347-52. PubMed ID: 9150853
[TBL] [Abstract][Full Text] [Related]
25. [Classic nitrate PETN (pentaerythritol tetranitrate). Initial data in pulmonary hypertension: no tolerance].
MMW Fortschr Med; 2002 Nov; 144(45):50. PubMed ID: 12534063
[No Abstract] [Full Text] [Related]
26. [Quantitative gas chromatography-mass spectrometry determination of pentaerythrityl tetranitrate metabolites pentaerythrityl trinitrate, pentaerythrityl dinitrate and pentaerythrityl in human plasma].
Schütz A; Kötting J; Epple F; Ziegler R; Maier-Lenz H; Stalleicken D
Arzneimittelforschung; 1999 Nov; 49(11):891-5. PubMed ID: 10604040
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of angina pectoris with special reference to beta-blockers].
Weser C
Z Arztl Fortbild (Jena); 1982 Mar; 76(6):239-43. PubMed ID: 6126050
[No Abstract] [Full Text] [Related]
28. [Latent and exertion cardiac insufficiency--an indication for nitrates].
Olthoff KH; Wustmann U
Z Gesamte Inn Med; 1981 Sep; 36(18):644-9. PubMed ID: 7314746
[TBL] [Abstract][Full Text] [Related]
29. The prescription pattern of oral nitrates in coronary artery disease. Appropriateness and cost considerations.
Reuveni H; Aviram EE; Elhayani A; Lifshitz M; Peled R; Galai N; Sherf M; Paran E
Eur J Clin Pharmacol; 2001 Oct; 57(8):595-7. PubMed ID: 11758638
[TBL] [Abstract][Full Text] [Related]
30. A liquid chromatographic-mass spectrometric procedure for analysis of pentaerythrityl tetranitrate metabolites - Development, validation and application to ovine serum and human plasma samples.
Städtler M; Wissenbach D; Wissenbach DK; Franke L; Pastuschek J; Schleussner E; Allison B; Peters FT; Groten T
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124028. PubMed ID: 38330519
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and methods of treatment of patients with stable coronary heart disease in the primary care settings--the results of the Polish, Multicentre Angina Treatment Pattern (ATP) study.
Ruzyllo W; Ponikowski P; Wilkins A;
Int J Clin Pract; 2004 Dec; 58(12):1127-33. PubMed ID: 15646410
[TBL] [Abstract][Full Text] [Related]
32. The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits.
Müllenheim J; Müller S; Laber U; Thämer V; Meyer W; Bassenge E; Fink B; Kojda G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):269-75. PubMed ID: 11521170
[TBL] [Abstract][Full Text] [Related]
33. The effect of an NO donor, pentaerythrityl tetranitrate, on biochemical, functional, and morphological attributes of cardiovascular system of spontaneously hypertensive rats.
Dovinová I; Cacányiová S; Fáberová V; Kristek F
Gen Physiol Biophys; 2009 Mar; 28(1):86-93. PubMed ID: 19390141
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
35. [Prescription of generic drugs to privately insured persons].
Wild F
Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709
[TBL] [Abstract][Full Text] [Related]
36. Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.
Italiano D; Capuano A; Alibrandi A; Ferrara R; Cannata A; Trifirò G; Sultana J; Ferrajolo C; Tari M; Tari DU; Perrotta M; Pagliaro C; Rafaniello C; Spina E; Arcoraci V
Br J Clin Pharmacol; 2015 Jun; 79(6):1010-9. PubMed ID: 25556909
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study.
Jurt U; Gori T; Ravandi A; Babaei S; Zeman P; Parker JD
J Am Coll Cardiol; 2001 Sep; 38(3):854-9. PubMed ID: 11527645
[TBL] [Abstract][Full Text] [Related]
38. Rapid microbial degradation of organic nitrates in rat excreta. Re-examination of the urinary and fecal metabolite profiles of pentaerythritol tetranitrate in the rat.
King SY; Fung HL
Drug Metab Dispos; 1984; 12(3):353-7. PubMed ID: 6145563
[TBL] [Abstract][Full Text] [Related]
39. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
Gatti A; Scotti G
Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
[No Abstract] [Full Text] [Related]
40. The effect of pentaerithrityl-tetranitrate on parameters of the microcirculation.
Böhm C; Haustein KO
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):398-402. PubMed ID: 9707356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
